Gateway(R) destination vector of AAV2 [reverse].
|
Other clones in our bank
External Database Reference sequence |
Sequence (full) | RDB15111zzk01.seq provided by the depositor |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions set forth by the DEPOSITOR | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Sohn, J. et al. PLoS One, 12 (1): e0169611, 2017) |
---|---|
Ordering | Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] |
Remarks | ((Remarks)) Use DB3.1(Invitrogen) or equivalent to amplify this clone. Remember that you will be working with samples containing infectious virus. |
提供条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Sohn, J. et al. PLoS One, 12 (1): e0169611, 2017)。 |
---|---|
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] |
備考 | 使用上の注意】このクローンの増殖にはDB3.1(Invitrogen)あるいは同等の宿主を使用してください。このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB15111 | pAAV2-DEST(r) | DNA solution |
Original reference
Further references such as user reports and related articles (go to bottom)
Featured content
Featured content | Empty Backbone (English text) |
---|---|
Featured content | Empty Backbone (Japanese text) |
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB15111_A7Fdp1-2.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: ccdB-C_F Region: ccdB 3', attR1, AAV2 ITR(R) Sequence file: RDB15111_A7Fda.seq |
---|
>D04569A5-1_A7Fd_ccdB-C_F_D01_04_ABI08.ab1 1 CTATTGGGGG GGGGGTGAAA ATCGGGGGGA TGAAGCTGGC GCATGATGAC CACCGATATG 61 GCCAGTGTGC CGGTCTCCGT TATCGGGGAA GAAGTGGCTG ATCTCAGCCA CCGCGAAAAT 121 GACATCAAAA ACGCCATTAA CCTGATGTTC TGGGGAATAT AAATGTCAGG CTCCCTTATA 181 CACAGCCAGT CTGCAGGTCG ATACAGTAGA AATTACAGAA ACTTTATCAC GTTTAGTAAG 241 TATAGAGGCT GAAAATCCAG ATGAAGCCGA ACGACTTGTA AGAGAAAAGT ATAAGAGTTG 301 TGAAATTGTT CTTGATGCAG ATGATTTTCA GGACTATGAC ACTAGCGTAT ATGAATAGGT 361 AGATGTTTTT ATTTTGTCAC ACAAAAAAGA GGCTCGCACC TCTTTTTCTT ATTTCTTTTT 421 ATGATTTAAT ACGGCATTGA GGACAATAGC GAGTAGGCTG GATACGACGA TTCCGTTTGA 481 GAAGAACATT TGGAAGGCTG TCGGTCGACT AAGTTGGCAG CATCACCCGA AGAACATTTG 541 GAAGGCTGTC GGTCGACTAC AGGTCACTAA TACCATCTAA GTAGTTGATT CATAGTGACT 601 GGATATGTTG TGTTTTACAG TATTATGTAG TCTGTTTTTT ATGCAAAATC TAATTTAATA 661 TATTGATATT TATATCATTT TACGTTTCTC GTTCAGCTTT TTTGTACAAA CTTGTCACGT 721 GCGGACCGAG CGGCCGCAGG AACCCCTAGT GATGGGAGTT GGCCACTCCC TCTCTGCGCG 781 CTC // |
Primer: Cm_M_R Region: CmR 5', cat pro, attR2, AAV2 ITR (L) Sequence file: RDB15111_A7Fdb.seq |
>D04569A5-1_A7Fd_Cm_M_R_C01_03_ABI08.ab1 1 TTGAGGAGGG GGAAACGTAT TCCCATTATT CACCAGCTCA CCGGTCTTTC ATTGGCCATA 61 CGGAATTCCG GATGAGCATT CATCAGGCGG GCAAGAATGT GAATAAAGGC CGGATAAAAC 121 TTGTGCTTAT TTTTCTTTAC GGTCTTTAAA AAGGCCGTAA TATCCAGCTG AACGGTCTGG 181 TTATAGGTAC ATTGAGCAAC TGACTGAAAT GCCTCAAAAT GTTCTTTACG ATGCCATTGG 241 GATATATCAA CGGTGGTATA TCCAGTGATT TTTTTCTCCA TTTTAGCTTC CTTAGCTCCT 301 GAAAATCTCG ATAACTCAAA AAATACGCCC GGTAGTGATC TTATTTCATT ATGGTGAAAG 361 TTGGAACCTC TTACGTGCCG ATCAACGTCT CATTTTCGCC AAAAGTTGGC CCAGGGCTTC 421 CCGGTATCAA CAGGGACACC AGGATTTATT TATTCTGCGA AGTGATCTTC CGTCACAGGT 481 ATTTATTCGG CGCAAAGTGC GTCGGGTGAT GCTGCCAACT TAGTCGACTA CAGGTCACTA 541 ATACCATCTA AGTAGTTGAT TCATAGTGAC TGGATATGTT GTGTTTTACA GTATTATGTA 601 GTCTGTTTTT TATGCAAAAT CTAATTTAAT ATATTGATAT TTATATCATT TTACGTTTCT 661 CGTTCAGCTT TCTTGTACAA AGTGGTACGC GTGCGGCCGC AGGAACCCCT AGTGATGGAG 721 TTGGCCCACT CCCTCTCTGC GCGCTCG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
2022.08.12
GNP_filter3_RDBDEP_html_220812.pl